DSO Equity for Dentists: What to Know Before You Invest in Your Employer
Private equity has brought a new vocabulary into dentistry. Partnership. Alignment. Doctor ownership. Shared equity. Second bite of the apple. The message is appealing: help build the organization and participate in the upside. For some dentists, that opportunity may prove financially rewarding. For others, private DSO equity can become an illiquid investment sitting beneath enormous corporate debt, governed by agreements the dentist did not negotiate and valued in a market where there may be no independent buyer. Before writing a check, the most useful question is simple: What exactly am I buying?
That question matters more after several large dental organizations confronted major debt restructurings. Dental Care Alliance completed a transaction in June 2026 that eliminated more than $1.1 billion of funded debt, added $95 million in new capital and extended remaining maturities to 2031. Affordable Care followed with a restructuring that eliminated approximately $1 billion, about 65 percent of its debt, brought in $75 million of new capital and transferred ownership to existing lenders. Aspen Group, parent of Aspen Dental, entered 2026 facing more than $3 billion of term loan maturities due in December 2027 and was pursuing a broad refinancing while its debt traded below face value. None of this proves misconduct or forced dentist investment. It does prove that a DSO can have hundreds of busy practices while the corporate entity above them carries a stressed capital structure.
The interest rate story also needs precision. Current rates are painful compared with the cheap money available during much of the previous decade, but they are nowhere near historical highs. The federal funds rate averaged 3.75 percent in September 2026. In June 1981 it averaged 19.10 percent. The extraordinary period was the long stretch of nearly free money that preceded the recent increases. Private equity could borrow cheaply, acquire practices and finance expansion. When that debt reprices several percentage points higher, the additional interest expense can become enormous.
Dentistry itself is providing less room for error. ADA Health Policy Institute data from the third quarter of 2026 showed softer patient demand, growing unused capacity and reimbursement increases that failed to keep pace with inflation. Thirty eight percent of dentists said they were not busy enough, while only 8 percent said they were too busy to treat everyone seeking care. From January through August, reimbursement rose about 1.5 percent while inflation increased 2.3 percent. Real dental spending weakened even as staffing remained difficult, particularly in hygiene. These conditions do not mean dentistry is collapsing. They do mean highly leveraged organizations have less cushion when patient traffic softens, wages rise and debt becomes more expensive.
That is where DSO equity becomes more complicated than the sales presentation. A dentist may hear that a company is worth hundreds of millions of dollars, but enterprise value does not reveal what common shareholders will ultimately receive. Debt holders are generally paid before common equity. Preferred investors may have liquidation rights ahead of ordinary shareholders. A company can therefore sell for an impressive amount while junior investors receive little or nothing. Affordable Care’s transfer of ownership to its lenders is a useful reminder that the relevant question is not simply what the company is worth, but how much debt and preferred capital stands between that valuation and the dentist’s shares.
Dilution deserves similar nuance. A dentist whose ownership falls from 5 percent to 1 percent has not automatically lost money. If new capital allows the company to grow dramatically, 1 percent of a much larger company can be worth more than the original 5 percent. Dilution becomes dangerous when new shares or senior securities are issued on terms that favor other investors, when minority owners lack information rights, or when the capital structure can change without meaningful protection.
Liquidity may be an even larger problem. Public shares can generally be sold at a quoted market price. Private DSO shares often cannot. The company may tell a dentist that a stake is worth $400,000, yet there may be no buyer willing or permitted to pay that amount. The shareholder agreement may allow the company to repurchase shares when the dentist quits or is terminated, and the price may be based on book value, fair market value or a company selected formula. Terms such as “good leaver” and “bad leaver” can determine whether years of paper appreciation survives departure from the organization.
Private securities are also more regulated than many dentists assume. Every securities transaction must either be registered with the SEC or qualify for an exemption, and exempt offerings remain subject to federal antifraud laws. Materially false or misleading statements about the company, its finances or the investment can still create liability. State securities laws may apply as well.
Rule 701 is frequently cited in employee equity discussions, but it is often misunderstood. It applies to compensatory securities issued by qualifying private companies in noncapital raising transactions. It does not impose a simple $1 million annual ceiling. Companies can issue more, and enhanced disclosure obligations become relevant when Rule 701 sales exceed $10 million during a 12 month period. If a DSO is granting equity or options as compensation, Rule 701 may apply. If the organization is asking dentists to invest personal cash as part of a capital raise, another exemption, such as Regulation D, may be more relevant.
Employment law adds another layer. California Labor Code Section 407 expressly prohibits making an investment or stock purchase part of the consideration required to secure employment, although California also recognizes legitimate employee stock purchase and option arrangements. Other states have different rules. A dentist being offered voluntary equity presents one situation. A dentist being told that hiring, continued employment, compensation or promotion depends upon writing a substantial personal check presents another and deserves independent legal review.
Taxes depend heavily on structure as well. Buying stock, receiving stock, receiving an option and exercising an option are not interchangeable events. The IRS distinguishes incentive stock options from nonstatutory options. An incentive stock option generally does not produce regular taxable income when granted or exercised, although exercise can create alternative minimum tax exposure. A nonstatutory option commonly creates compensation income when exercised based on the difference between the exercise price and fair market value. Saying that a stock purchase automatically creates an immediate tax bill is therefore inaccurate. Dentists need to know precisely what security they are receiving and when taxes could arise.
The broader debate over “employee ownership” has added confusion. Traditional Employee Stock Ownership Plans are ERISA governed retirement plans with fiduciary, valuation and participant protections. Private equity firms have also developed broad based equity programs that allow employees to participate economically when a portfolio company grows and is sold. Ownership Works, associated with KKR executive Pete Stavros, promotes such programs and says employees ordinarily receive the equity without investing their own money. These programs can create real wealth, but they are structurally different from traditional ESOPs and generally do not provide the same governance or retirement plan protections.
Critics, including The ESOP Association, argue that some newer proposals blur those distinctions and use the language of employee ownership without equivalent protections. Supporters respond that conventional ESOPs are impractical for many large companies and that giving rank and file workers equity they otherwise would never receive still has real value. Both arguments deserve scrutiny. What should not be done is to combine free employee equity, traditional ESOPs and mandatory employee investment into a single category. A worker receiving equity at no cost faces a fundamentally different risk from a dentist being asked to invest $100,000 of personal savings.
That distinction matters because claims of widespread DSO coercion have begun circulating within dentistry. The underlying concern is credible. Private DSO equity can be difficult to value, highly illiquid and vulnerable to corporate leverage, and employment linked investment can create serious conflicts of interest. What remains poorly documented is how common actual coercion has become. There is no reliable prevalence study showing that DSO dentists are increasingly being threatened with termination, reduced compensation or other consequences unless they purchase company equity. Individual cases may exist, but anecdotes do not establish an industry wide rate.
Dentists should therefore resist both extremes. “Private equity is a scam” is too crude to guide a financial decision, and “you are becoming an owner” is too vague to justify one. The documents matter more than either sales pitch. Before investing, understand the fully diluted ownership percentage, corporate debt, interest expense, preferred securities, liquidation priorities, valuation method, dilution protections, information rights, repurchase provisions and what happens upon resignation, termination, disability or death. Find out whether the company can issue securities senior to yours and what happened to dentist investors during previous refinancings or recapitalizations. Ask how and when the investment can actually become cash.
The lawyer reviewing those documents should represent the dentist, not the DSO. The same is true of the CPA or tax adviser. Employer counsel already has a client.
Dentistry has now produced several billion dollars of real world evidence that large dental organizations can become overleveraged even while their practices continue treating patients every day. That does not make DSO equity inherently bad. It means private company ownership deserves the same scrutiny a dentist would bring to buying another practice, purchasing commercial real estate or placing a large portion of retirement savings into any single investment.
If your DSO asked you to invest tomorrow, would you know exactly who gets paid before you do?
Join the Conversation!